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The yeast two-hybrid (Y2H) system exploits host cell genetics in order to display binary
protein–protein interactions (PPIs) via defined and selectable phenotypes. Numerous
improvements have been made to this method, adapting the screening principle for
diverse applications, including drug discovery and the scale-up for proteome wide
interaction screens in human and other organisms. Here we discuss a systematic
workflow and analysis scheme for screening data generated by Y2H and related assays
that includes high-throughput selection procedures, readout of comprehensive results
via next-generation sequencing (NGS), and the interpretation of interaction data via
quantitative statistics. The novel assays and tools will serve the broader scientific
community to harness the power of NGS technology to address PPI networks in health
and disease. We discuss examples of how this next-generation platform can be applied
to address specific questions in diverse fields of biology and medicine.
Keywords: protein–protein interactions, yeast two-hybrid, interactome mapping, next-generation sequencing,
quantitative interaction profiles
INTRODUCTION
Networks of protein–protein interactions (PPIs) govern essentially all biological processes
and mechanisms, such as receptor-ligand recognition, immune responses, intracellular and
extracellular signaling, growth regulation, and development. Early on, PPI networks or
“interactomes” were recognized as the next frontier in biomedicine after the completion of the
human genome project (Mendelsohn and Brent, 1999). The role of interaction networks in
complex diseases is now a central focus in network biology (Vidal et al., 2011; Sharma et al., 2015).
Innovative concepts and technologies are therefore required to satisfy a broad and unmet need for
highly reliable and eﬃcient mapping of PPIs.
The charting of interactomes is in many ways more challenging than that of genomes. Proteins
are encoded by multiple transcript isoforms and are localized in diverse cellular compartments
with distinct milieus. Moreover, variations in amino acids and post-translational modiﬁcations
aﬀect and determine PPIs. Hence, from a practical perspective, working with proteins is more
demanding than working with DNA. For these reasons, to this date, our technical capabilities
for systematic approaches toward PPI networks remain limited, when compared with the routine
deciphering of genomes, transcriptomes, and exomes at high eﬃciency and low cost by next-
generation sequencing (NGS) technologies (Shendure, 2011; Shendure and Lieberman Aiden,
2012; Mardis, 2013).
Over the last 30 years, diverse technologies have been developed to detect PPIs that are based
on diﬀerent principles with individual strengths and weaknesses. Aﬃnity puriﬁcation followed
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by mass-spectrometry (AP-MS) is the standard method to
identify protein complexes (Bensimon et al., 2012; Dunham et al.,
2012). On the other hand, a variety of assays, such as yeast
two-hybrid (Y2H), as well as protein fragment complementation
(PCA) in yeast and various mammalian assays, are currently
applied for the in vivo screening of binary interactions to identify
direct binding partners (Stynen et al., 2012). These assays rely
on the reconstitution of PPIs in vivo and the direct or indirect
activation of reporters for selection and scoring of interactions.
Since its inception (Fields and Song, 1989; Gyuris et al.,
1993), Y2H has emerged as a widely applied approach for
the exploration of novel PPIs and interactome-wide screens
(Vidal and Fields, 2014). The assay relies on the splitting of
a transcription factor into its DNA binding and activation
domains. In most implementations, the bait protein is fused
to the DNA binding domain, whereas the prey or a library
of prey cDNAs is fused to the activation domain. A physical
interaction between bait and prey reconstitutes the transcription
factor and activates one or several reporter genes, allowing
selection of yeast cells expressing interacting bait-prey pairs.
After selection for growth, only a small minority of cells with
interacting proteins is enriched over a large background of cells
containing non-interacting proteins. Y2H provides therefore a
genetic selection system, in which interaction partners can be
identiﬁed by sequencing the DNA encoding the prey proteins that
interact with a deﬁned bait protein.
A variety of other existing in vivo assays for screening binary
PPIs can be considered alternative implementation of Y2H
principles, such as split ubiquitin system for membrane proteins
(Obrdlik et al., 2004; Jones et al., 2014), the reverse Y2H screening
system and the two-bait interaction trap to explore the eﬀect
of allelic variants on PPIs (Vidal et al., 1996; Xu et al., 1997).
The yeast one-hybrid technique is a variant for the identiﬁcation
of proteins that bind to DNA motifs and transcription factor
binding sites (Fuxman Bass et al., 2015). With yeast three-
hybrid (Y3H) the goal is identiﬁcation of proteins binding to
small molecule drugs (protein-drug interactions; PDIs; Moser
and Johnsson, 2013).
In this article, we give an overview on existing methods
that present diﬀerent solutions to use NGS as readout for Y2H
data. We also present our own experimental and bioinformatics
platform that we developed for this purpose and discuss howNGS
can overcome the existing limitations of Y2H and diverse other
binary interaction assays.
YEAST TWO-HYBRID TECHNOLOGIES
AND MAPPING OF INTERACTOMES
High-throughput Y2H assays have been instrumental in
proteome-wide screens for the mapping of PPIs that were so
far undertaken in human and various model organisms (Uetz
et al., 2000; Rual et al., 2005; Stelzl et al., 2005; Yu et al., 2008;
Simonis et al., 2009; Rolland et al., 2014). A recent focus for
high-throughput Y2H is on diﬀerential PPIs of normal and
disease-associated alleles occurring in the human population
(Dittmer et al., 2014; Sahni et al., 2015). In matrix-based Y2H
procedures, comprehensive collections of bait and prey strains
are combined in high-throughput, using robotic infrastructure
(Uetz et al., 2000, 2004; Stelzl et al., 2005). Yeast clones are
arrayed on deﬁned matrix positions, therefore PPIs are scored
as visual readouts, eliminating the need to do DNA sequencing
for identiﬁcation. Moreover, the use of annotated full-length
open reading frames (ORFs) also circumvents potential artifacts
that are associated with cDNA libraries. On the other hand, the
requirement for preassembled and deﬁned libraries restricts this
method to human and well-deﬁned model organisms for which
ORF collections have been made. Moreover, the automated setup
that is required for this approach is expensive and not readily
available for many researchers.
Despite the importance of Y2H as a discovery system,
most Y2H results, also those generated in high-throughput
experiments, are not based on truly quantitative measurements.
This contrasts with gene expression and protein–DNA
interactions which have been systematically explored with
DNA microarrays and NGS. Notably, the use of DNA
microarrays for parallel identiﬁcation of Y2H screening
results was recognized early on (Cho et al., 1998). More recently,
a microarray-Y2H screening and scoring system was introduced
and applied to identify interaction partners of huntingtin and
ataxin-1, two important determinants for neurodegenerative
diseases (Suter et al., 2013). Using the Qi-Sampler repeat
sampling tool (Fontaine et al., 2011), microarray-Y2H results
were benchmarked against sets of known positives (golden
sets) and other gene sets for statistical enrichments. High-
conﬁdence microarray-Y2H interactions correlated with
positives from the literature and PPIs that were conﬁrmed
with luminescence-based mammalian interactome mapping
as an alternative assay. Moreover, the quantitative scoring of
interaction data and comparison to background controls allowed
the elimination of many non-speciﬁc binders or sticky prey
proteins.
The ﬁrst adaptation of NGS technology for Y2H came
from the lab of Marc Vidal (Yu et al., 2011). In the Stitch-
Seq method, the sequences of putatively interacting bait and
prey proteins are concatenated so that they comprise a single
amplicon for a massive and parallel NGS readout. The method
was successfully used to generate high-throughput Y2H datasets
(Rolland et al., 2014). The Y2H-Seq approach by the group of
Ulrich Stelzl relies on the combination of NGS with matrix
Y2H (Weimann et al., 2013). It demonstrated the advantages
of the NGS readout for scalability by sequencing the results
of hundreds of separate screens through barcode indexing in
a single Illumina run. A higher interaction coverage in the
screened interactome space was achieved by increasing the
sensitivity for detection of PPIs. The Y2H-Seq screens resulted
in a network of 523 interactions involving 22 methyltransferases
or demethylases for previously undiscovered cellular roles in
non-histone protein methylation. However, while Y2H-Seq and
Stitch-Seq are powerful tools and pioneering implementations
of NGS for Y2H, they are intended for interactome screenings
with ORF libraries and aim primarily at increasing scale and
sensitivity but do not fully exploit the quantitative potential
of NGS.
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A NEXT GENERATION SOLUTION FOR
Y2H SCREENS
We believe that the perceived shortcomings of Y2H such as
inconsistent or non-reproducible results, lack of quantitation,
laborious procedures, and above all, high rates of false positive
results can be traced to the lack of an adequate readout
system. With next-generation interaction screening (NGIS), we
developed an innovative concept and methodology to harness
the power of NGS technologies for the exploration of PPIs.
The application of NGS removes the main restrictions on Y2H
imposed by the cost of DNA sequencing. Replacing conventional
Sanger sequencing with NGS leads to a massively increased
throughput while reducing the cost of sequencing per screen
to a small fraction of the conventional readouts (1,000–10,000-
fold or more). Currently we are providing screening services for
clients that include experimental work, data analysis, and the use
of a cloud-based platform (Figure 1). NGIS procedures can be
applied to every available Y2H and Y2H variant setup for binary
interaction screens.
The technical principle of NGIS is shown in Figure 2. Tissue-
or organ derived cDNA libraries that were cloned into Y2H
prey vectors are combined with individual Y2H bait strains
via cDNA transformation and mating procedures, and grown
on selective medium. Selected prey cDNA clones are then
ampliﬁed and products are fragmented and sequenced at their
entire lengths with Illumina MiSeq or HiSeq. Most important,
entire pools are sequenced after unbiased selection without the
need to isolate individual clones. Another beneﬁt of the NGIS
protocol is that multiple repeat screens can now be undertaken
to screen at maximum sensitivity, such that a weak enrichment
corresponding to a single clone can be detected in a larger overall
population and maximum coverage of the interaction space is
achieved.With bioinformatics tools and algorithms adapted from
RNA-Seq analytical methods, NGIS data can be processed to
assign fold change and false discovery rate for every cDNA clone
being sequenced in the assay. By comparing replicated bait results
with controls (unrelated baits), the maximum information can
be extracted out of the assays, scoring false positives and also
taking into account the occurrence of false negatives and the
reproducibility of the screening results.
With substantial cost reduction for screening and sequencing,
it is worthwhile to generate large repeat datasets only for the
purpose of screening the background of non-speciﬁc interactions.
Indeed, non-speciﬁc Y2H activation by a subset of prey cDNAs
(sticky preys) often makes up a majority of all hits in a
FIGURE 1 | Pipeline for Next-generation interaction sequencing (NGIS). Specific target binding in Y2H (or related assays) results in distinct populations of
cDNAs that are identified and quantified via NGS. Interactions are scored and interpreted in a bioinformatics pipeline with quantitative statistics.
FIGURE 2 | Screening principle and applications for NGIS. Experimental scheme for NGS based interaction profiling. Bait-specific screening results/profiles are
compared to original cDNA pools and control screens to uncover background and non-specific interactions. Prey cDNAs that interact with the bait are enriched and
quantitated using next-generation sequencing (NGS) and bioinformatics analysis. Bait-specific enrichments (blue) can be quantitatively distinguished from
non-specific enrichments (red) and non-selected preys (orange, green).
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Y2H screen (Uetz, 2002). Hence, without prior knowledge,
conventional Y2H requires speciﬁcity tests to conﬁrm each
identiﬁed PPI after the screening procedure is done, usually by
isolation of cDNAs and retests with control strains (Vidalain
et al., 2004). Using the NGIS screening scheme, bait speciﬁc
DNA enrichments can be scored for speciﬁcity and non-
speciﬁc interactions can be excluded a priori. This closes an
existing gap to other technologies, such as AP-MS for which
control datasets for background contaminants are routinely
applied to distinguish bona ﬁde interactors from non-speciﬁc
contaminants (Lavallée-Adam et al., 2011; Mellacheruvu et al.,
2013). Importantly, Y2H screening data can be viewed and
interpreted as interaction proﬁles, comparable to transcription
proﬁles in RNA sequencing (Trapnell et al., 2012; Law et al.,
2014). Quantitative comparisons between diﬀerent screen sets
allow data mining and predictions for gene function that are
impossible to do with the conventional Y2H readout by Sanger
sequencing (Suter et al., 2013).
With NGIS interaction and interactome proﬁles, binary
interaction screens can be adapted in several ways and toward
diﬀerent goals (Table 1). The primary goal in most Y2H
screens is to deﬁne the function of proteins by identifying
their molecular neighborhoods and to ﬁnd speciﬁc targets that
are relevant in diseases, e.g., proteins with functions in cancer
or host receptors for pathogen eﬀector proteins in microbial
pathogenesis. NGIS interaction proﬁles and gene enrichment
analysis help to understand the function of proteins of interest
and the search for relevant interaction targets. An approach
related to ours, Quantitative Interactor Sequencing (Qi-Seq),
applied the split-ubiquitin system and Illumina NGS to screen for
plant host targets for the HopZ2 eﬀector protein that is secreted
by the Gram-negative bacterial pathogen Pseudomonas syringae,
and identiﬁed the Arabidopsis thalianaMLO2 protein as a target
(Lewis et al., 2012).
Besides the discovery of novel PPIs, NGIS also provides a
systematic approach to address changes in interaction proﬁles
introduced by variants and polymorphisms in proteins that
underlie phenotypes in complex and inheritable diseases. A
number of studies have shown that Y2H assay is well-suited to
detect changes in PPIs that are introduced by disease-speciﬁc
alleles or random-generated amino acid mutations (Vidal et al.,
1996; Xu et al., 1997; Dreze et al., 2009; Rolland et al., 2014).
TABLE 1 | Solutions provided by NGIS for diverse problems and
applications.
Area Problem Solution
Biological pathways Mechanism of diverse
diseases
Comparative interaction
profiling
Microbial pathogenesis Host virulence
determinants
Comparative interaction
profiling
Complex and
inheritable diseases
Variants of unknown
significance
Parallel interaction
fingerprints
Protein engineering Determinants of protein
and peptide binding
Complete interaction
landscapes
Drug discovery Search for drug targets Three-hybrid target
discovery
A recent study proﬁled the interactions of several thousand
missense mutations across a spectrum of Mendelian disorders
(Sahni et al., 2015). The analysis indicated that two-thirds of
disease-associated alleles perturb PPIs, while common variants
from healthy individuals rarely aﬀect interactions. Our NGIS
platform provides a rapid way to compare PPI patterns from
wild-type and mutant versions of the same protein. Quantitative
Y2H data will not only show presence or absence of individual
PPIs, but also shift in overall interaction patterns, which may
cause gain or loss of protein function.
PERSPECTIVES AND FUTURE
CHALLENGES
An immediate use of NGS based interaction screens with Y2H
or Y2H variant techniques can be seen in the extraction of
valuable and speciﬁc leads from quantitative and comprehensive
interaction proﬁles. PPI proﬁles can be from wild-type and
mutant proteins, as well as from isoforms of the same proteins,
and also from full length proteins and their individual domains.
Often, researchers are not interested in the complete set PPIs
exhibited by a target of interest, but rather in a set of PPIs that
are altered in disease. By providing an eﬀective way to discover
diﬀerential or regulated PPIs, NGIS could therefore constitute an
important application to explore biological pathways and disease
mechanisms.
Other areas in which NGIS could have an impact are protein
engineering and target discovery for small molecule drugs (see
Table 1). Considering that protein domains rather than full-
length proteins are at the basic level of proteome organization,
screening for protein fragments often reveals speciﬁc interaction
sites and also PPIs that are masked in full length-proteins by
steric hindrance. The value of fragment-based Y2H approaches
was demonstrated previously (Boxem et al., 2008; Waaijers et al.,
2013). NGS with complex cDNA libraries for high-resolution
mapping of interaction sites could therefore be instrumental to
achieve a full coverage of the protein interaction space. Reducing
the lengths of interaction motifs further down to peptides,
NGIS can also be applied for peptide aptamers for which Y2H
has been instrumental (Bickle et al., 2006; Hamdi and Colas,
2012). We can also envision a role for NGIS procedures for the
selection and optimization of scaﬀolds for aptamer displays. For
example, libraries of novel aptamer scaﬀolds could be selected
that can be targeted to diseased tissue and used both extra- and
intracellularly. Scaﬀolds could then be optimized for functional
interactions with proteins of interest.
Within the proper framework, NGIS could also, in principle,
be applied for Y2H-based protein-drug interactions, such as Y3H
to screen for novel protein targets that bind to known drugs
(Moser and Johnsson, 2013), or to address the disruption of PPIs
and protein complexes by small molecule binding (Flusin et al.,
2012). The screening and selection in small volumes of liquid
culture as opposed to large volumes of agar plates is a prerequisite
for eﬃcient screens in the presence of drugs. Quantitative analysis
of NGIS data could be used to eﬀectively distinguish drug-speciﬁc
from non-speciﬁc interactions.
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By providing quantitative measurements, reproducibility by
repeat assays, background controls for false positives, streamlined
scoring and statistical analysis, NGIS overcomes existing
bottlenecks of Y2H, thus providing a valuable technology and
service platform. In addition, reconstruction of the components
for Y2H fusion expression and reporter selection could increase
accuracy, speed, automation, and cost-eﬀectiveness for Y2H
screens. A wide repertoire of sequence elements and well-
characterized parts is now available for this purpose, although
less attention had been paid to PPI and interaction aﬃnities than
to transcription parameters (Galdzicki et al., 2011). Regulated
promoters that could compensate for diﬀerential expression of
individual bait proteins could allow a better comparison between
diﬀerent interaction proﬁles. Another area for improvements is
the use of new reporter assays to score interactions. For example,
ﬂuorescence measurements by cytometry for Y2H were already
recognized as an alternative to the existing reporter systems
(Chen et al., 2008). We expect that improved Y2H and Y2H-like
assays will unlock the full potential of interaction screening and
therefore provide a great beneﬁt for biological and biomedical
sciences.
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